Waleed Ghanima

Head of Research and Consultant Hematologist
Department of Medicine, Østfold Hospital Trust
Kalnes, Ostfold, Norway

Presentation(s):

• PB0363 - Development and internal validation of a simple clinical score for the evaluation of deep vein thrombosis

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0692 - Effect of thrombopoietin receptor agonists on coagulation factors, von Willebrand factor and ADAMTS13 in patients with immune thrombocytopenia.

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0917 - Long-term recurrence after subsegmental pulmonary embolism compared to more proximal pulmonary embolism - findings from the TROLL registry.

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0716 - VAYHIT: A clinical trial program evaluating the efficacy and safety of the anti-B-cell-activating factor receptor (BAFF-R)/B-cell-depleting monoclonal antibody ianalumab in patients with primary ITP

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• SOA 16.1 - Adult ITP: Changing the natural history in the 21st century

  Tuesday, June 25, 2024
  08:00 – 08:20 ICT

• PB1416 - Occult cancer in patients diagnosed with VTE: incidence and evaluation of diagnostic routines – data from the TROLL-registry

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT

• OC 70.1 - Outcome of Patients Treated with Antibiotics Prior to Pulmonary Embolism Diagnosis

  Wednesday, June 26, 2024
  10:15 – 10:30 ICT

• OC 70.3 - Exercise capacity in dyspneic persons with a recent acute pulmonary embolism

  Wednesday, June 26, 2024
  10:45 – 11:00 ICT

• OC 74.3 - Development of a new disease-specific health-related quality of life questionnaire for deep vein thrombosis

  Wednesday, June 26, 2024
  10:45 – 11:00 ICT

• OC 74.5 - Exercise capacity, dyspnoea and health-related quality of life six months after rehabilitation in patients with persistent dyspnoea following pulmonary embolism

  Wednesday, June 26, 2024
  11:15 – 11:30 ICT